Soleus Capital Management, L.P. - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 199 filers reported holding TRANSMEDICS GROUP INC in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.

Quarter-by-quarter ownership
Soleus Capital Management, L.P. ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q2 2023$6,231,316
+333.1%
74,200
+290.5%
0.69%
+365.1%
Q1 2023$1,438,870
-46.4%
19,000
-56.3%
0.15%
-61.3%
Q4 2022$2,684,820
-63.3%
43,500
-75.2%
0.38%
-61.3%
Q3 2022$7,317,000
+26.1%
175,300
-5.0%
0.99%
+9.8%
Q2 2022$5,801,000184,4550.90%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q4 2022
NameSharesValueWeighting ↓
Sandhill Capital Partners LLC 1,805,518$34,594,0002.69%
Millrace Asset Group, Inc. 83,723$1,604,0000.94%
Bullseye Asset Management LLC 117,031$2,218,0000.88%
Taylor Wealth Management Partners 72,782$1,395,0000.49%
MOODY ALDRICH PARTNERS LLC 166,078$3,182,0000.44%
HARBOURVEST PARTNERS LLC 116,123$2,225,0000.28%
NEXT CENTURY GROWTH INVESTORS LLC 161,819$3,100,0000.28%
EMERALD MUTUAL FUND ADVISERS TRUST 300,492$5,757,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 82,255$1,576,0000.18%
EMERALD ADVISERS, LLC 244,816$4,691,0000.17%
View complete list of TRANSMEDICS GROUP INC shareholders